Bipartisan Insulin Price Cap Legislation Gains Congressional Support
Bipartisan legislation to cap insulin costs at $35 per month for people with private insurance gained four new co-sponsors, including Republican and Democratic senators. The bill was originally introduced in March and is building momentum in Congress. The legislation addresses concerns about insulin affordability, a critical issue for millions of Americans with diabetes.
Legislation designed to cap monthly insulin costs at $35 for individuals with private insurance continues to attract bipartisan support in Congress. The bill, which was introduced in March, added four new co-sponsors on Monday, including Senators Joni Ernst (R-Iowa) and John Hickenlooper (D-Colo.), demonstrating cross-party backing for the measure. The growing number of co-sponsors suggests the proposal is gaining traction among lawmakers from both parties. Insulin affordability has become an increasingly prominent healthcare policy issue, with many Americans reporting difficulty affording the medication despite having insurance coverage. The momentum behind this legislation reflects broader congressional interest in addressing prescription drug costs.
What's missing
The article excerpt does not provide details on the bill's specific legislative status, timeline for consideration, or potential opposition to the measure.
What different sources said
- The HillCenter
Insulin legislation gains steam
Related
U.S. Pressures Europe to Tighten Travel Restrictions on Ebola-Affected African Countries
The Trump administration has called on European nations to impose stricter travel measures for people coming from Ebola-affected regions in the Democratic Republic of the Congo and Uganda, with Secretary of State Marco Rubio warning that failure to do so could result in increased U.S. travel restrictions on Europe. The U.S. has already implemented a three-week travel ban from affected countries and contributed over $200 million to outbreak response efforts. The pressure comes as the FIFA World Cup opens in Mexico on June 11, 2026, with the U.S. hosting most games, and reflects concerns about the higher volume of transatlantic travel compared to direct Africa-U.S. flights.
Actor Tyler Mane Reveals Breast Cancer Diagnosis, Plans to Raise Awareness
Tyler Mane, 59, best known for playing Sabretooth in the 2000 'X-Men' film, announced he has been diagnosed with breast cancer and is beginning chemotherapy treatment. Male breast cancer is rare, affecting fewer than 1% of all breast cancer cases and one in 750 men, and is often diagnosed at later stages due to low awareness. Mane plans to document his treatment journey to encourage other men to recognize symptoms and seek early diagnosis.
Study Links Glucosamine Supplement to Faster Alzheimer's Progression in People with Mild Cognitive Impairment
Researchers at the University of Florida found that people with mild cognitive impairment who took glucosamine were 25% more likely to progress to dementia, and glucosamine users with Alzheimer's disease showed a 25% increase in mortality risk. The study analyzed health records from over 4,600 patients combined with brain imaging and mouse models, published in Nature Metabolism. The findings suggest glucosamine may interfere with metabolic processes already disrupted in Alzheimer's disease, though researchers emphasize the results do not prove causation and require confirmation through clinical trials.